*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Perospirone</strong> is a novel atypical antipsychotic agent developed for the treatment of schizophrenia. It acts as a potent antagonist at dopamine D2 and serotonin 5-HT2A receptors. The chemical structure features a piperazine derivative core with the molecular formula <strong>C26H31N3O4S</strong> and CAS number <strong>118709-36-1</strong>.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical manufacturing for oral tablet formulations targeting positive and negative symptoms of psychosis.</li>
<li>Research applications in neuropharmacology studies regarding receptor binding affinity.</li>
<li>Contract manufacturing organization (CMO) services for active pharmaceutical ingredient (API) synthesis.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated for patients with severe central nervous system depression or known hypersensitivity to the compound. Storage requires keeping the API in a cool, dry place below 25°C away from direct sunlight to maintain stability and potency.</p>